First Time Loading...
I

Inner Mongolia Furui Medical Science Co Ltd
SZSE:300049

Watchlist Manager
Inner Mongolia Furui Medical Science Co Ltd
SZSE:300049
Watchlist
Price: 51 CNY -0.43%
Updated: May 3, 2024

Inner Mongolia Furui Medical Science Co Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Inner Mongolia Furui Medical Science Co Ltd
Revenue Peer Comparison

Comparables:
H
3692
600436
600276
000538
C
300765

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
I
Inner Mongolia Furui Medical Science Co Ltd
SZSE:300049
Revenue
¥1B
CAGR 3-Years
7%
CAGR 5-Years
4%
CAGR 10-Years
9%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Revenue
¥10.1B
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Revenue
¥9.7B
CAGR 3-Years
14%
CAGR 5-Years
16%
CAGR 10-Years
22%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Revenue
¥22.3B
CAGR 3-Years
-5%
CAGR 5-Years
7%
CAGR 10-Years
14%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Revenue
¥39.1B
CAGR 3-Years
6%
CAGR 5-Years
8%
CAGR 10-Years
9%
C
CSPC Innovation Pharmaceutical Co Ltd
SZSE:300765
Revenue
¥2.5B
CAGR 3-Years
24%
CAGR 5-Years
15%
CAGR 10-Years
N/A

See Also

What is Inner Mongolia Furui Medical Science Co Ltd's Revenue?
Revenue
1B CNY

Based on the financial report for Mar 31, 2023, Inner Mongolia Furui Medical Science Co Ltd's Revenue amounts to 1B CNY.

What is Inner Mongolia Furui Medical Science Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
9%

Over the last year, the Revenue growth was 12%. The average annual Revenue growth rates for Inner Mongolia Furui Medical Science Co Ltd have been 7% over the past three years , 4% over the past five years , and 9% over the past ten years .